Back to Search Start Over

RIT1 regulation of CNS lipids RIT1 deficiency Alters cerebral lipid metabolism and reduces white matter tract oligodendrocytes and conduction velocities.

Authors :
Wu L
Wang F
Moncman CL
Pandey M
Clarke HA
Frazier HN
Young LEA
Gentry MS
Cai W
Thibault O
Sun RC
Andres DA
Source :
Heliyon [Heliyon] 2023 Sep 23; Vol. 9 (10), pp. e20384. Date of Electronic Publication: 2023 Sep 23 (Print Publication: 2023).
Publication Year :
2023

Abstract

Oligodendrocytes (OLs) generate lipid-rich myelin membranes that wrap axons to enable efficient transmission of electrical impulses. Using a RIT1 knockout mouse model and in situ high-resolution matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) coupled with MS-based lipidomic analysis to determine the contribution of RIT1 to lipid homeostasis. Here, we report that RIT1 loss is associated with altered lipid levels in the central nervous system (CNS), including myelin-associated lipids within the corpus callosum (CC). Perturbed lipid metabolism was correlated with reduced numbers of OLs, but increased numbers of GFAP <superscript>+</superscript> glia, in the CC, but not in grey matter. This was accompanied by reduced myelin protein expression and axonal conduction deficits. Behavioral analyses revealed significant changes in voluntary locomotor activity and anxiety-like behavior in RIT1 <superscript> KO </superscript> mice. Together, these data reveal an unexpected role for RIT1 in the regulation of cerebral lipid metabolism, which coincide with altered white matter tract oligodendrocyte levels, reduced axonal conduction velocity, and behavioral abnormalities in the CNS.<br />Competing Interests: Ramon C. Sun has received research support and has received a consultancy fee from Maze Therapeutics. Matthew S. Gentry has received research support and research compounds from Maze Therapeutics, Valerion Therapeutics, and Ionis Pharmaceuticals. Matthew S. Gentry also received a consultancy fee from Maze Therapeutics, PTC Therapeutics, and the Glut1-Deficiency Syndrome Foundation. Fang Wang, Lei Wu, Mritunjay Pandey, Harrison A. Clarke, Hilaree N. Frazier, Carole L. Moncman, Weikang Cai, Lyndsay E.A. Young, Olivier Thibault, and Douglas A. Andres report no disclosures. The content is the responsibility of the authors and does not necessarily represent the official views of the NIH. The paper is subject to the NIH Public Access Policy. This study was carried out in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.<br /> (© 2023 The Authors. Published by Elsevier Ltd.)

Details

Language :
English
ISSN :
2405-8440
Volume :
9
Issue :
10
Database :
MEDLINE
Journal :
Heliyon
Publication Type :
Academic Journal
Accession number :
37780758
Full Text :
https://doi.org/10.1016/j.heliyon.2023.e20384